GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » S&S Healthcare Holding Ltd (ROCO:4198) » Definitions » EV-to-EBIT

S&S Healthcare Holding (ROCO:4198) EV-to-EBIT : 8.97 (As of May. 27, 2024)


View and export this data going back to 2013. Start your Free Trial

What is S&S Healthcare Holding EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, S&S Healthcare Holding's Enterprise Value is NT$927.7 Mil. S&S Healthcare Holding's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was NT$103.4 Mil. Therefore, S&S Healthcare Holding's EV-to-EBIT for today is 8.97.

The historical rank and industry rank for S&S Healthcare Holding's EV-to-EBIT or its related term are showing as below:

ROCO:4198' s EV-to-EBIT Range Over the Past 10 Years
Min: -26.04   Med: -5.31   Max: 12.6
Current: 8.97

During the past 13 years, the highest EV-to-EBIT of S&S Healthcare Holding was 12.60. The lowest was -26.04. And the median was -5.31.

ROCO:4198's EV-to-EBIT is ranked better than
79.42% of 452 companies
in the Medical Devices & Instruments industry
Industry Median: 20.2 vs ROCO:4198: 8.97

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. S&S Healthcare Holding's Enterprise Value for the quarter that ended in Mar. 2024 was NT$885.3 Mil. S&S Healthcare Holding's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was NT$103.4 Mil. S&S Healthcare Holding's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 11.68%.


S&S Healthcare Holding EV-to-EBIT Historical Data

The historical data trend for S&S Healthcare Holding's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

S&S Healthcare Holding EV-to-EBIT Chart

S&S Healthcare Holding Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.44 -5.29 -5.81 -10.85 5.63

S&S Healthcare Holding Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.01 -12.51 -10.42 5.63 8.56

Competitive Comparison of S&S Healthcare Holding's EV-to-EBIT

For the Medical Devices subindustry, S&S Healthcare Holding's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


S&S Healthcare Holding's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, S&S Healthcare Holding's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where S&S Healthcare Holding's EV-to-EBIT falls into.



S&S Healthcare Holding EV-to-EBIT Calculation

S&S Healthcare Holding's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=927.672/103.436
=8.97

S&S Healthcare Holding's current Enterprise Value is NT$927.7 Mil.
S&S Healthcare Holding's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$103.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


S&S Healthcare Holding  (ROCO:4198) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

S&S Healthcare Holding's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=103.436/885.2994
=11.68 %

S&S Healthcare Holding's Enterprise Value for the quarter that ended in Mar. 2024 was NT$885.3 Mil.
S&S Healthcare Holding's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$103.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


S&S Healthcare Holding EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of S&S Healthcare Holding's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


S&S Healthcare Holding (ROCO:4198) Business Description

Traded in Other Exchanges
N/A
Address
7th Floor, Number 89, Xinhu 1st Road, Taipei, TWN, 114
S&S Healthcare Holding Ltd, formerly Swissray Global Healthcare Holding Ltd is involved in providing DR systems designed for any application in general radiography. The product divisions of the company cover Swissray DDR systems, Novadaq, and EZ2GO. The main business projects of the company and its subsidiaries are the research and development, manufacturing, sales, and maintenance services of high-end medical equipment and the manufacturing and sales of basic medical equipment.

S&S Healthcare Holding (ROCO:4198) Headlines

No Headlines